NATCO Pharma Limited (BOM: 524816)
India flag India · Delayed Price · Currency is INR
1,418.75
0.00 (0.00%)
At close: Dec 20, 2024

NATCO Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Market Capitalization
253,790170,522102,795138,013150,52992,044
Upgrade
Market Cap Growth
62.65%65.89%-25.52%-8.31%63.54%-12.17%
Upgrade
Enterprise Value
231,309160,84193,605133,992144,00584,751
Upgrade
Last Close Price
1418.75948.61555.81740.10802.16488.33
Upgrade
PE Ratio
13.0512.2814.3781.1834.1419.97
Upgrade
PS Ratio
5.574.263.807.097.324.81
Upgrade
PB Ratio
3.552.912.113.243.652.43
Upgrade
P/TBV Ratio
3.683.012.193.343.662.44
Upgrade
P/FCF Ratio
18.7519.5514.63-340.56149.42
Upgrade
P/OCF Ratio
14.8214.0712.11296.8050.3822.06
Upgrade
EV/Sales Ratio
5.074.023.466.887.004.43
Upgrade
EV/EBITDA Ratio
9.749.199.6851.5423.7414.56
Upgrade
EV/EBIT Ratio
10.5610.2411.56108.5829.1917.45
Upgrade
EV/FCF Ratio
17.0618.4413.32-325.80137.58
Upgrade
Debt / Equity Ratio
0.030.070.040.100.070.09
Upgrade
Debt / EBITDA Ratio
0.090.220.181.640.470.57
Upgrade
Debt / FCF Ratio
0.150.440.25-6.425.35
Upgrade
Asset Turnover
0.630.640.500.390.440.43
Upgrade
Inventory Turnover
0.940.940.780.660.660.63
Upgrade
Quick Ratio
3.872.722.472.022.482.23
Upgrade
Current Ratio
4.964.144.393.504.463.39
Upgrade
Return on Equity (ROE)
31.23%25.88%15.66%4.05%11.19%12.59%
Upgrade
Return on Assets (ROA)
18.89%15.63%9.40%1.56%6.57%6.83%
Upgrade
Return on Capital (ROIC)
21.22%17.39%10.39%1.69%7.24%7.60%
Upgrade
Earnings Yield
7.65%8.14%6.96%1.23%2.93%5.01%
Upgrade
FCF Yield
5.33%5.11%6.84%-1.35%0.29%0.67%
Upgrade
Dividend Yield
0.41%1.00%0.99%0.61%0.65%1.38%
Upgrade
Payout Ratio
5.10%12.30%14.04%48.35%25.83%27.65%
Upgrade
Buyback Yield / Dilution
1.16%1.67%-0.08%0.05%-0.02%1.26%
Upgrade
Total Shareholder Return
1.16%2.68%0.91%0.65%0.63%2.64%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.